Squarepoint’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.1M Sell
50,672
-23,922
-32% -$519K ﹤0.01% 1481
2025
Q1
$1.81M Sell
74,594
-37,111
-33% -$900K ﹤0.01% 1216
2024
Q4
$2.33M Buy
111,705
+30,842
+38% +$644K ﹤0.01% 1094
2024
Q3
$1.61M Buy
80,863
+62,591
+343% +$1.24M ﹤0.01% 1219
2024
Q2
$283K Sell
18,272
-170,088
-90% -$2.63M ﹤0.01% 1991
2024
Q1
$3M Buy
+188,360
New +$3M 0.01% 896
2023
Q4
Sell
-41,798
Closed -$489K 2567
2023
Q3
$489K Buy
+41,798
New +$489K ﹤0.01% 1654
2023
Q2
Sell
-66,586
Closed -$1.1M 2458
2023
Q1
$1.1M Buy
+66,586
New +$1.1M ﹤0.01% 1109
2022
Q1
Sell
-89,336
Closed -$605K 2324
2021
Q4
$605K Buy
+89,336
New +$605K ﹤0.01% 1491
2021
Q2
Sell
-75,781
Closed -$349K 2679
2021
Q1
$349K Sell
75,781
-26,575
-26% -$122K ﹤0.01% 1780
2020
Q4
$342K Buy
102,356
+38,099
+59% +$127K ﹤0.01% 1773
2020
Q3
$191K Buy
+64,257
New +$191K ﹤0.01% 1954
2020
Q2
Sell
-247,194
Closed -$952K 2190
2020
Q1
$952K Sell
247,194
-756,848
-75% -$2.91M 0.02% 733
2019
Q4
$3.77M Buy
1,004,042
+989,519
+6,813% +$3.71M 0.02% 587
2019
Q3
$77K Sell
14,523
-25,977
-64% -$138K ﹤0.01% 2109
2019
Q2
$156K Buy
+40,500
New +$156K ﹤0.01% 2085
2019
Q1
Sell
-45,147
Closed -$87K 2130
2018
Q4
$87K Buy
+45,147
New +$87K ﹤0.01% 1794
2018
Q3
Sell
-201,450
Closed -$629K 2006
2018
Q2
$629K Buy
201,450
+72,950
+57% +$228K 0.01% 1083
2018
Q1
$307K Sell
128,500
-58,143
-31% -$139K ﹤0.01% 1302
2017
Q4
$730K Buy
186,643
+109,743
+143% +$429K 0.01% 968
2017
Q3
$194K Buy
76,900
+16,400
+27% +$41.4K ﹤0.01% 1381
2017
Q2
$167K Buy
+60,500
New +$167K ﹤0.01% 1335
2017
Q1
Sell
-18,000
Closed -$19K 1560
2016
Q4
$19K Buy
+18,000
New +$19K ﹤0.01% 1727
2016
Q3
Sell
-41,400
Closed -$29K 1045
2016
Q2
$29K Buy
+41,400
New +$29K ﹤0.01% 1050